The model for end‐stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end‐stage liver disease: A prospective cohort study

Javier Murillas, Antonio Rimola, Montserrat Laguno, Elisa de Lazzari, Javier Rascón, Fernando Agüero, José L. Blanco, Eduardo Moitinho, Asunción Moreno, José M. Miró, ESLD‐HIV Working Group Investigators – 28 August 2009 – End‐stage liver disease (ESLD) has become the main cause of mortality in patients coinfected by human immunodeficiency virus (HIV) and hepatitis B virus or hepatitis C virus in developed countries. The aim of this study was to describe the natural history of and prognostic factors for ESLD, with particular attention paid to features affecting liver transplantation.

Subscribe to